Notably, this association remained significant even after adjusting for age, adiposity measures, HOMA-IR score, the PNPLA3 genetic variant, or other NAFLD-related genetic polymorphisms that confer a greater susceptibility to NAFLD and NASH. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.